Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNG001 in COPD with Respiratory Virus
NCT03570359Phase 2Completed
- Sponsor
- Synairgen
- Start
- Jan 2018
- Primary completion
- May 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in chronic obstructive pulmonary disease (COPD), sponsored by Synairgen. Started Jan 2018; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03570359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570359.